JP2018502824A5 - - Google Patents

Download PDF

Info

Publication number
JP2018502824A5
JP2018502824A5 JP2017521145A JP2017521145A JP2018502824A5 JP 2018502824 A5 JP2018502824 A5 JP 2018502824A5 JP 2017521145 A JP2017521145 A JP 2017521145A JP 2017521145 A JP2017521145 A JP 2017521145A JP 2018502824 A5 JP2018502824 A5 JP 2018502824A5
Authority
JP
Japan
Prior art keywords
radionuclide
njugeto
radioisotope
complex according
target molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017521145A
Other languages
English (en)
Japanese (ja)
Other versions
JP6689836B2 (ja
JP2018502824A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2015/050640 external-priority patent/WO2016058056A1/en
Publication of JP2018502824A publication Critical patent/JP2018502824A/ja
Publication of JP2018502824A5 publication Critical patent/JP2018502824A5/ja
Priority to JP2020065981A priority Critical patent/JP6905121B2/ja
Application granted granted Critical
Publication of JP6689836B2 publication Critical patent/JP6689836B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017521145A 2014-10-16 2015-10-16 新規なイメージング組成物およびその使用 Active JP6689836B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2020065981A JP6905121B2 (ja) 2014-10-16 2020-04-01 新規なイメージング組成物およびその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2014904138 2014-10-16
AU2014904138A AU2014904138A0 (en) 2014-10-16 Novel imaging composition and uses thereof
PCT/AU2015/050640 WO2016058056A1 (en) 2014-10-16 2015-10-16 Novel imaging composition and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020065981A Division JP6905121B2 (ja) 2014-10-16 2020-04-01 新規なイメージング組成物およびその使用

Publications (3)

Publication Number Publication Date
JP2018502824A JP2018502824A (ja) 2018-02-01
JP2018502824A5 true JP2018502824A5 (enExample) 2018-12-06
JP6689836B2 JP6689836B2 (ja) 2020-04-28

Family

ID=55745889

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017521145A Active JP6689836B2 (ja) 2014-10-16 2015-10-16 新規なイメージング組成物およびその使用
JP2020065981A Active JP6905121B2 (ja) 2014-10-16 2020-04-01 新規なイメージング組成物およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020065981A Active JP6905121B2 (ja) 2014-10-16 2020-04-01 新規なイメージング組成物およびその使用

Country Status (9)

Country Link
US (4) US9980930B2 (enExample)
EP (2) EP3207027B1 (enExample)
JP (2) JP6689836B2 (enExample)
CN (2) CN107250104B (enExample)
AU (1) AU2015333599B2 (enExample)
CA (1) CA2983459C (enExample)
ES (2) ES2980073T3 (enExample)
NZ (1) NZ731966A (enExample)
WO (1) WO2016058056A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9980930B2 (en) 2014-10-16 2018-05-29 The University Of Melbourne Imaging composition and uses thereof
EP4649966A3 (en) 2016-12-01 2026-02-18 Regeneron Pharmaceuticals, Inc. Radiolabeled anti-pd-l1 antibodies for immuno-pet imaging
EA201991673A1 (ru) 2017-02-10 2020-01-17 Регенерон Фармасьютикалз, Инк. Меченные радиоактивным изотопом антитела к lag3 для иммуно-пэт-визуализации
SG11202000073XA (en) 2017-07-24 2020-02-27 Regeneron Pharma Anti-cd8 antibodies and uses thereof
DE102018126558A1 (de) * 2018-10-24 2020-04-30 Helmholtz-Zentrum Dresden - Rossendorf E.V. Markierungsvorläufer mit Quadratsäure-Kopplung
US20220017433A1 (en) * 2018-11-21 2022-01-20 Universität Zürich Photochemically induced conjugation of radiometals to small molecules, peptides and nanoparticles in a simultaneous one-pot reaction
CN118526580A (zh) * 2019-06-21 2024-08-23 瑞泽恩制药公司 结合psma和cd3的双特异性抗原结合分子与4-1bb共刺激组合的用途
EP3986934A1 (en) * 2019-06-21 2022-04-27 Regeneron Pharmaceuticals, Inc. Use of bispecific antigen-binding molecules that bind muc16 and cd3 in combination with 4-1bb co-stimulation
AU2020349462A1 (en) 2019-09-16 2022-03-03 Regeneron Pharmaceuticals, Inc. Radiolabeled MET binding proteins for immuno-PET imaging
CN114502528B (zh) * 2019-09-20 2024-09-06 墨尔本大学 成像和治疗组合物
US20230372551A1 (en) * 2020-09-22 2023-11-23 Memorial Sloan-Kettering Cancer Center Radiolabeled ligands for targeted pet/spect imaging and methods of their use
CN118317957A (zh) * 2021-09-29 2024-07-09 墨尔本大学 在靶向放射疗法应用中作为配体的含大环的化合物和其放射性标记的络合物
AU2023242087A1 (en) * 2022-03-30 2024-09-12 Nihon Medi-Physics Co., Ltd. Method for producing complex

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917826A (en) * 1985-10-18 1990-04-17 The Upjohn Company Cyclic hydrocarbons with an aminoalkyl sidechain
US5145874A (en) * 1985-10-18 1992-09-08 The Upjohn Company Cyclic hydrocarbons with an aminoalkyl sidechain
ES2272099T3 (es) * 1998-10-16 2007-04-16 Ge Healthcare Bio-Sciences Ab Composicion estable en el almacenamiento que comprende un soporte activado por acido escuarico utilizable para la inmovilizacion de compuestos que contienen grupos de amina.
CN1905900A (zh) * 2003-11-28 2007-01-31 米特拉医药股份公司 Erb抗原的靶向作用
DK1791565T3 (en) * 2004-09-23 2016-08-01 Genentech Inc Cysteingensplejsede antibodies and conjugates
US20100111856A1 (en) * 2004-09-23 2010-05-06 Herman Gill Zirconium-radiolabeled, cysteine engineered antibody conjugates
FR2914304B1 (fr) 2007-03-28 2012-11-16 Guerbet Sa Composes pour le diagnostic de maladies liees a l'expression de vcam.
US9980930B2 (en) 2014-10-16 2018-05-29 The University Of Melbourne Imaging composition and uses thereof

Similar Documents

Publication Publication Date Title
JP2018502824A5 (enExample)
JP2018521121A5 (enExample)
JP2012255026A5 (enExample)
JP2016508134A5 (enExample)
JP2012509348A5 (enExample)
JP2013509429A5 (enExample)
JP2013522326A5 (enExample)
JP2015508103A5 (enExample)
JP2017517565A5 (enExample)
JP2018522867A5 (enExample)
JP2011518833A5 (enExample)
JP2020532547A5 (enExample)
JP2017516775A5 (enExample)
JP2017526677A5 (enExample)
JP2016518337A5 (enExample)
JP2016536286A5 (enExample)
JP2017504611A5 (enExample)
MX2018006370A (es) Inhibidores de proteina quinasa, metodo de preparacion y su uso medico.
JP2015508092A5 (enExample)
JP2017514910A5 (enExample)
JP2015511609A5 (enExample)
JP2015516419A5 (enExample)
JP2016512227A5 (enExample)
JP2020523327A5 (enExample)
JP2015528814A5 (enExample)